Tag School of Pharmacy

New technology promises to help drug makers go green

June 16, 2010

Production of a single kilogram of pharmaceuticals often yields hundreds of kilograms of chemical waste. Now, new chemistry developed by scientists at UW, combined with technology developed by researchers from Eli Lilly and Company, promises to dramatically reduce that waste stream for a key step in the pharmaceutical production process.

Students care for the community at MEDiC clinics

February 26, 2010

People and Programs Campaign a big winner for School of Pharmacy

February 9, 2010

The University of Wisconsin–Madison School of Pharmacy raised more than $22 million in its six-year People and Programs Campaign, topping its goal of $18 million.

St. Jude CEO to deliver 2009 Rennebohm lecture

August 26, 2009

William E. Evans, chief executive officer of St. Jude’s Children’s Research Hospital and an expert on the treatment of pediatric cancer, and a research leader in the effect of genetics to the response to drugs, will deliver the 2009 Rennebohm Lecture on Thursday, Sept. 10.

Review begins for pharmacy dean

April 22, 2009

A review is under way for School of Pharmacy Dean Jeanette Roberts.

Engineered bacterium churns out two new key antibiotics

February 18, 2009

In recent years, scientists have isolated two potent natural antibiotics - platensimycin and platencin - that are highly effective against bacterial infection, including those caused by the most dreaded drug-resistant microbes.

Psychoactive compound activates mysterious receptor

February 12, 2009

A hallucinogenic compound found in a plant indigenous to South America and used in shamanic rituals regulates a mysterious protein that is abundant throughout the body, University of Wisconsin–Madison researchers have discovered.

Genetic change prevents cell death in mouse model of Parkinson’s disease

February 2, 2009

By shifting a normal protective mechanism into overdrive, a University of Wisconsin–Madison scientist has completely shielded mice from a toxic chemical that would otherwise cause Parkinson's disease.

Genetic change extends mouse life, points to possible treatment for ALS

December 9, 2008

There are many ways to die, but amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, must be one of the worst. By the time a patient notices muscle weakness, the neurons that control the muscles have already begun dying, in an untreatable process that brings death within two to five years.

Pharmacy classmates remember Nickel

October 6, 2008

More than 45,000 runners are expected to participate in the Bank of America Chicago Marathon on Saturday, Oct. 12. University of Wisconsin–Madison student Sarah Balzar will have more on her mind that day than simply finishing with a fast time.

School of Pharmacy ready to celebrate 125 years

January 22, 2008

What began as an inspiration of several forward-thinking pharmacists throughout the state is now, 125 years later, a national leader in advancing both the practice and science of pharmacy.

Using evolution, UW team creates a template for many new therapeutic agents

September 10, 2007

By guiding an enzyme down a new evolutionary pathway, a team of University of Wisconsin–Madison researchers has created a new form of an enzyme capable of producing a range of potential new therapeutic agents with anticancer and antibiotic properties.

Fishing for new anti-inflammatory, cancer drugs

April 10, 2007

Though cell movement and migration in the body play a central role in mediating injury and disease, including inflammatory responses and cancer metastasis, drugs designed to stifle cells’ nomadic tendencies are scarce. A new interdisciplinary research project funded by the Wisconsin Institutes for Discovery seed grant program seeks to develop a novel drug-discovery process that may start to fill this gap.

Nanoscale packaging could aid delivery of cancer-fighting drugs

February 15, 2007

A University of Wisconsin–Madison pharmacy professor aims to improve the delivery of cancer-fighting drugs by targeting them more selectively to tumors and boosting their solubility in water.